Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy

Gastrointestinal Endoscopy

Volumn 70, Issue 2, 2009, Pages 262-268

  Amorós, Amparo ^a   Aparicio, José R ^a   Garmendia, Marta ^a   Casellas, Juan A ^a   Martínez, Juan ^a   Jover, Rodrigo ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROPOFOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DEEP SEDATION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEPATIC ENCEPHALOPATHY; HUMAN; HYPOTENSION; HYPOXEMIA; LIVER CIRRHOSIS; MALE; OPEN STUDY; PRIORITY JOURNAL; PSYCHOMETRY; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

COHORT STUDIES; CONSCIOUS SEDATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPNOTICS AND SEDATIVES; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROPOFOL; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 67650789809     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2008.10.038     Document Type: Article

References (27)

1. Assy N., Rosser B.G., Grahame G.R., et al. Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. Gastrointest Endosc 49 (1999) 690-694
2. Habib A., and Sanyal A.J. Acute variceal hemorrhage. Gastrointest Endosc Clin N Am 17 (2007) 223-252 v
3. Karan S.B., and Bailey P.L. Update and review of moderate and deep sedation. Gastrointest Endosc Clin N Am 14 (2004) 289-312
4. MacGilchrist A.J., Birnie G.G., Cook A., et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut 27 (1986) 190-195
5. McGuire B.M. Safety of endoscopy in patients with end-stage liver disease. Gastrointest Endosc Clin N Am 11 (2001) 111-130
6. Vasudevan A.E., Goh K.L., and Bulgiba A.M. Impairment of psychomotor responses after conscious sedation in cirrhotic patients undergoing therapeutic upper GI endoscopy. Am J Gastroenterol 97 (2002) 1717-1721
7. Cohen L.B., Delegge M.H., Aisenberg J., et al. AGA Institute review of endoscopic sedation. Gastroenterology 133 (2007) 675-701
8. Ortiz M., Jacas C., and Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42 Suppl (2005) S45-S53
9. Quero J.C., and Schalm S.W. Subclinical hepatic encephalopathy. Semin Liver Dis 16 (1996) 321-328
10. Romero-Gomez M., Boza F., Garcia-Valdecasas M.S., et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96 (2001) 2718-2723
11. Servin F., Cockshott I.D., Farinotti R., et al. Pharmacokinetics of propofol infusions in patients with cirrhosis. Br J Anaesth 65 (1990) 177-183
12. Weston B.R., Chadalawada V., Chalasani N., et al. Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients. Am J Gastroenterol 98 (2003) 2440-2447
13. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34 (2001) 768-773
14. Romero G.M., Cordoba J., Jover R., et al. Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy. [Spanish with English abstract]. Med Clin (Barc) 127 (2006) 246-249
15. Kircheis G., Wettstein M., Timmermann L., et al. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35 (2002) 357-366
16. Romero-Gomez M., Cordoba J., Jover R., et al. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45 (2007) 879-885
17. Aldrete J.A., and Kroulik D. A postanesthetic recovery score. Anesth Analg 49 (1970) 924-934
18. Butterworth R.F. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol 32 (2000) 171-180
19. Goulenok C., Bernard B., Cadranel J.F., et al. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther 16 (2002) 361-372
20. Groeneweg M., Quero J.C., De Bruijn I., et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28 (1998) 45-49
21. Jover R., Company L., Gutierrez A., et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol 98 (2003) 1599-1604
22. Jover R., Company L., Gutierrez A., et al. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 42 (2005) 659-665
23. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 102 (2007) 1903-1909
24. Hartmann I.J., Groeneweg M., Quero J.C., et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 95 (2000) 2029-2034
25. Romero-Gomez M., Grande L., Camacho I., et al. Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 37 (2002) 781-787
26. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
27. Quero J.C., Hartmann I.J., Meulstee J., et al. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 24 (1996) 556-560